^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Rectal Cancer
    Drug:Fruzaqla (fruquintinib) (VEGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    11/16/2023
    Excerpt:
    Rectal Cancer: SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Fruquintinib…